Back to results
US 2022/0064183 A1Published application
Heteroaryl compounds useful as mk2 inhibitors
AssigneeCelgene CAR LLC
InventorsJian Guo, John Malona, Alexander L. Ruchelman, Sekhar S. Surapaneni
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
Claims15
1-10. (canceled)
A compound of Formulae V, V′, or V″:
- or a pharmaceutically acceptable salt thereof, wherein:
- each of R7, R7′, R8, R8′, R8″, R9, Rxa, Rxb, Rya, and Ryb is independently hydrogen or deuterium
- wherein the compound is other than.
12-14. (canceled)
(canceled)
18-20. (canceled)
Dependencies are inferred from the claim text.